Novel Surrogate Markers as Predictors of Radiation Toxicity in Breast Cancer Patients Undergoing Helical Tomotherapy Compared to Standard Radiation Therapy
Status: TERMINATED
Study type: OBSERVATIONAL
Conditions: Genetic Markers|Cardiac Toxicity|Breast and Skin Motion
Sponsor: AHS Cancer Control Alberta